Literature DB >> 2849592

Cellular polypeptides overexpressed after herpes simplex infection permit virus subtyping and may help diagnose cervical cancer.

J M Davis1, N B La Thangue, D L Taylor, D S Latchman, M Anderson, A S Tyms.   

Abstract

The synthesis of cellular macromolecules is inhibited after infection with herpes simplex viruses (HSV) although certain host proteins accumulate to high concentrations as identified by monoclonal antibody TG7A. By western blotting, a polypeptide with a relative molecular weight of 90 kilodaltons was identified in cells infected with type 2 viruses and a polypeptide of 40 kilodaltons relative molecular weight in type 1 infected cells, and virus typing was confirmed by restriction enzyme analysis of viral DNA. Thirty seven clinical isolates from the genital region were subtyped as HSV type 2 and 18 from the orofacial region as type 1 by the different intracellular location of the 90 kilodalton and 40 kilodalton proteins seen on immunofluorescent staining of cells infected with HSV. Expression of these proteins has been associated with cellular transformation due to gene products of HSV or other viruses. Overexpression of the cellular proteins identified by TG7A reactivity was shown to be a marker for cells in cervical smears from patients with CIN III that appeared to be dyskaryotic. Little or no reaction was observed in squamous epithelial cells found in normal or abnormal smears.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849592      PMCID: PMC1194252          DOI: 10.1136/sti.64.5.321

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  22 in total

1.  Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  Nat New Biol       Date:  1971-09-08

2.  Human papillomavirus type-16 homologous DNA in normal human ectocervix.

Authors:  M F Cox; C A Meanwell; N J Maitland; G Blackledge; C Scully; J A Jordan
Journal:  Lancet       Date:  1986-07-19       Impact factor: 79.321

3.  The structure of herpes simplex virus DNA and its application to molecular epidemiology.

Authors:  T G Buchman; T Simpson; C Nosal; B Roizman; A J Nahmias
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

4.  A comparative analysis of restriction enzyme digests of the DNA of herpes simplex virus isolated from genital and facial lesions.

Authors:  S M Chaney; K G Warren; J Kettyls; A Zbitnue; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

5.  Tumour production by HSV-2 transformed lines in rats and the varying response to immunosuppression.

Authors:  J C MacNab
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

6.  The polypeptide and the DNA restriction enzyme profiles of spontaneous isolates of herpes simplex virus type 1 from explants of human trigeminal, superior cervical and vagus ganglia.

Authors:  K G Warren; H Koprowski; D M Lonsdale; S M Brown; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

7.  Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?

Authors:  H zur Hausen
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

8.  Characterization of herpes simplex virus strains isolated from patients with various diseases.

Authors:  S Dundarov; P Andonov; B Bakalov
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Conversion of herpetic lesions to malignancy by ultraviolet exposure and promoter application.

Authors:  J C Burns; B K Murray
Journal:  J Gen Virol       Date:  1981-08       Impact factor: 3.891

10.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  1 in total

Review 1.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.